FDA WARNING_LETTER - CAMA Wellness Center/IodoRios Company, LLC - March 02, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA and FTC issued a Warning Letter to IodoRios, LLC on March 5, 2021, regarding the sale of unapproved and misbranded products related to COVID-19. The agencies reviewed the company's websites, www.cp.camacenter.com and www.facebook.com/IoWipe, on February 8 and March 2, 2021, respectively.
The FDA observed that IodoRios, LLC offers a hand wipe product for sale in the United States, claiming it mitigates, prevents, treats, diagnoses, or cures COVID-19. This product is deemed an unapproved new drug, violating section 505(a) of the FD&C Act (21 U.S.C. § 355(a)), and a misbranded drug under section 502 (21 U.S.C. § 352). The introduction of this product into interstate commerce is prohibited under sections 301(a) and (d) of the FD&C Act (21 U.S.C. § 331(a) and (d)).
The letter cites the public health emergency and national emergency declarations for COVID-19, emphasizing FDA's urgent measures to protect consumers from unauthorized products. IodoRios, LLC is required to immediately cease selling all unapproved and unauthorized products for COVID-
ID · 3dde5c45-6793-4a63-8930-14b31a634c4c
Full citation text and observation details available on the Dashboard.